Company: PTPI
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001104659-25-025104
Chunk: 79

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 79
---
<div align='center'>[Signature page follows.]

A-1</div>

Annex B

<div align='center'>THIRD AMENDMENT TO
Amended and restated Petros Pharmaceuticals, Inc.
2020 Omnibus Incentive Compensation PLAN</div>

Thisthird Amendment To amended and restated Petros Pharmaceuticals, Inc. 2020 Omnibus Incentive Compensation Plan(this “Amendment”), effective as of _____________, 2025 is
made and entered into by Petros Pharmaceuticals, Inc., a Delaware corporation (the “Company”). Terms used
in this Amendment with initial capital letters that are not otherwise defined herein shall have the meanings ascribed to such terms in
the Amended and Restated Petros Pharmaceuticals, Inc. 2020 Omnibus Incentive Compensation Plan (the “Plan”).

<div align='center'>RECITALS</div>

WHEREAS,
Section 17(a) of the Plan provides that the Board of Directors of the Company (the “Board”) may amend
the Plan at any time and from time to time, provided that the Board shall not amend the Plan without stockholder approval if such approval
is required in order to comply with the Code or any other applicable law, or to comply with the applicable stock exchange requirements;

WHEREAS,
the Board desires to amend the Plan to increase the aggregate number of shares of Common Stock that may be issued under the Plan, as
set forth in Section 4(a) of the Plan, by an additional 1,000,000,000 shares of Common Stock; and

WHEREAS,
the Board intends to submit this Amendment to the Company’s stockholders for their approval in accordance with Section 17(a) of
the Plan.

NOW, THEREFORE, in accordance with Section 17(a) of the Plan, and subject to approval of the Company’s stockholders,
the Company hereby amends the Plan, effective as of the date hereof, as follows:

1. Section 4(a) of
the Plan is hereby amended by deleting said section in its entirety and substituting in lieu thereof the following new Section 4(a):

(a) Shares Authorized. Subject to adjustment as described below in Sections 4(b) and 4(e), the maximum aggregate number of shares of Common Stock that may be issued or transferred under the Plan with respect to Awards made on and after the Effective Date shall be 1,002,760,000 shares. In addition, and subject to adjustment as described below in